To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
GTCR lands $900m pharmaceutical exit
The Chicago-based private equity firm originally invested $150m in Ovation Pharmaceuticals seven years ago.
